GGrantIndex
Sort

64,565 grants matching drug discovery

Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches

$596,334
Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U01 · FY2018 · CA

Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches

$596,334
Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U01 · FY2021 · CA

Enhancing Chemoradiation Efficacy through Unbiased Drug Discovery Approaches

$596,334
Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA

Mitochondrial Copper Biology

$596,322
Vishal Mahendrasingh Gohil · Texas A&M Agrilife Research · R35 · FY2025 · GM

A transformative drug discovery platform for allosteric kinase inhibitors

$596,314
Nicholas Mark Levinson · University Of Minnesota · R01 · FY2021 · CA

Ion Channel Screening Using Photoswitches

$596,204
Andrew Blatz · Photoswitch Biosciences, Inc. · R44 · FY2014 · GM

Dissecting triazole resistance and transcriptional regulation of ergosterol homeo

$596,131
Haoping Liu · University Of California-Irvine · R01 · FY2013 · AI

Protozoan Population Genetics and Inflammation

$596,125
Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Unlocking the Potential of PI3K Inhibition in CLL

$596,117
Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2018 · CA

FBPase inhibitors for glycemic control in diabetes

$596,094
Ontogen Corporation · R44 · FY2002 · DK

Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary Fibrosis

$596,061
Susanne Heynen-Genel · Sanford Burnham Prebys Medical Discovery Institute · R33 · FY2024 · HL

MOLECULAR SYNTHESIS AND CHARACTERIZATION CORE (MSCC)

$596,055
Richard Clinton Becker · Duke University · U54 · FY2016 · HL

Conus Peptides and Their Receptor Targets

$596,000
Baldomero M Olivera · University Of Utah · P01 · FY2013 · GM

UCSD Cancer Center Training Program in Drug Development

$595,993
Michael Bouvet · University Of California, San Diego · T32 · FY2020 · CA

Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels

$595,967
Diomedes E Logothetis · Northeastern University · R01 · FY2023 · NS

Discovery of in vivo small molecules for hearing protection against cisplatin and noise

$595,909
Jian Zuo · St. Jude Children'S Research Hospital · R01 · FY2016 · DC

Regulation of Neurogenesis by Stress and Antidepressants

$595,882
Irwin Lucki · University Of Pennsylvania · U01 · FY2006 · MH

Towards Therapeutics for Neurodegenerative Diseases

$595,852
Stanley B Prusiner · University Of California, San Francisco · R37 · FY2011 · AG

Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase

$595,852
Patrick G. Harran · University Of California Los Angeles · R01 · FY2015 · DK

Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish

$595,804
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2022 · HL

Identification and characterization of chemical probes for interrogation of the NEK family of kinases in cancer

$595,679
David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA

Lead optimization of DHODH inhibitors for malaria

$595,447
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2017 · AI

Lead optimization of DHODH inhibitors for malaria

$595,447
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2015 · AI

Lead optimization of DHODH inhibitors for malaria

$595,447
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2016 · AI

Lead optimization of DHODH inhibitors for malaria

$595,447
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2014 · AI